Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Aug;15(8):535-41.
doi: 10.1046/j.1525-1497.2000.04029.x.

Postmenopausal estrogen therapy and depressive symptoms in older women

M A Whooley  1 , D Grady, J A Cauley
Affiliations

Postmenopausal estrogen therapy and depressive symptoms in older women

M A Whooley et al. J Gen Intern Med. 2000 Aug.

Abstract

Background: Evidence regarding the effect of postmenopausal estrogen therapy on mood is limited.

Methods: To determine whether postmenopausal estrogen therapy is associated with fewer depressive symptoms in elderly women, we conducted a cross-sectional study of 6, 602 white women ages 71 years or older who were recruited from population-based listings in Baltimore, Md; Minneapolis, Minn; Portland, Ore; and the Monongahela Valley, Pa. Use of estrogen and progestin was determined by interview. Participants completed the Geriatric Depression Scale short form (GDS) and were considered depressed if they reported 6 or more of 15 possible symptoms of depression.

Results: A total of 6.3% (72/1,150) of current estrogen users, 7.2% (142/1,964) of past estrogen users, and 9.0% (313/3,488) of never users reported 6 or more symptoms of depression (P =.004). Current estrogen users had a decreased risk of reporting 6 or more depressive symptoms, compared with not current (past or never) users of estrogen (odds ratio [OR], 0.7; 95% CI, 0.5 to 0.9; P =.01], adjusted for living alone, bilateral oophorectomy, current smoking, physical activity, social network, self-perceived health, cognitive function, functional status, and antidepressant use. However, excluding women who use estrogen or progestin alone, we were unable to find an association between current use of combined estrogen plus progestin therapy and depressive symptoms (adjusted OR, 0.8; 95% CI, 0.5 to 1.4; P =.5).

Conclusions: This cross-sectional study found that current use of unopposed estrogen was associated with a decreased risk of depressive symptoms in older women. Additional studies are needed to understand the effect of combined estrogen and progestin therapy on the prevalence of depressive symptoms in older women.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Proportion of elderly women with 6 or more symptoms of depression by estrogen use.
See this image and copyright information in PMC

References

    1. Depression Guideline Panel. Depression in Primary Care. Vol 1: Detection and Diagnosis. Clinical Practice Guideline. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993. AHCPR 93–0550.
    1. Joffe H, Cohen LS. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry. 1998;44:798–811. - PubMed
    1. Jensvold MF, Halbreich U, Hamilton JA. Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC: American Psychiatric Press; 1996. eds.
    1. Stahl SM. Basic psychopharmacology of antidepressants, part 2: estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry. 1998;4:15–24. - PubMed
    1. Dennerstein L, Burrows GD, Hyman GJ, Sharpe K. Hormone therapy and affect. Maturitas. 1979;1:247–59. - PubMed

Publication types